PSMA ligands bind to prostate-specific membrane antigen, an enzyme most highly expressed
in prostate cancer cells. The high specificity of binding is the reason of their use in nuclear medicine. The products labeled with fluorine-18 and gallium-68 are used for diagnostic purposes. Radiopharmaceuticals with lutetium-177 and actinium-225 are used to treat the specific diseases.
Made on